about
Stress regulation in multiple sclerosis-current issues and conceptsEstrogen and testosterone therapies in multiple sclerosis.Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.Sex-related factors in multiple sclerosis susceptibility and progression.Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.The XX sex chromosome complement in mice is associated with increased spontaneous lupus compared with XY.Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imagingChanges of Motivational Variables in Patients with Multiple Sclerosis in an Exercise Intervention: Associations between Physical Performance and Motivational Determinants.Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation.Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?The role of stress-response systems for the pathogenesis and progression of MS.Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone.Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.Estrogen treatment in multiple sclerosisBehavioral interventions in multiple sclerosis: a biopsychosocial perspective.Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity.Depressive syndromes in neurological disorders.Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis.Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.Hypertension and hypothalamo-pituitary-adrenal axis hyperactivity affect frontal lobe integrity.Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial.Biological outcome measurements for behavioral interventions in multiple sclerosis.Correlates of cognitive dysfunction in multiple sclerosis.Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis.Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.Prolactin stimulation in multiple sclerosis--an indicator of disease subtypes and activity?Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls.Steroid regulation of T cell function appears unaltered in borderline personality disorder.Stronger endocrine responses after brief psychological stress in women at familial risk of breast cancer.Endocrine and cytokine responses to standardized physical stress in multiple sclerosis.Childhood trauma in multiple sclerosis: a case-control study.Higher Beck depression scores predict delayed epinephrine recovery after acute psychological stress independent of baseline levels of stress and mood.
P50
Q22241797-D846E3BE-7548-4128-A8B3-EB976DFA32A7Q34610594-869DEE3B-4BE9-45A3-A90C-64BB1730BA27Q34610688-8050FCA0-1AE3-462E-9E5F-C6A7D0BEB0C9Q35065539-5C2DCF4D-2E96-4E21-95E1-B7B95626CBF7Q35619427-BE623BD0-C789-4EED-8084-6A1E75FDEE99Q35672483-F8E2363E-7EAB-47A8-A55F-69503DC5FB73Q35674459-A7EB0415-15DE-4FA0-8098-2DC11712F6D8Q35800453-9FF7A17C-B221-4AB5-90C4-5A22BB7141A1Q35889718-56FE0F06-76AE-4D37-9CC7-0F8BA2B36C43Q36109858-A7907B14-0005-47BD-B601-92D5D6715835Q36134737-FFBA3C61-D440-40A8-91DE-4D80907B745EQ36226201-686FC736-0E54-468A-817F-C80A53B791D1Q36281410-6DE01790-0E5E-45F4-AD4D-D70121022EDAQ36764298-7DC446A7-E41F-45E8-B243-FCA515D1360DQ36841506-7B5E0419-BB1D-4E9B-B69F-F89CB144D1E1Q36865770-9E408EA1-9DDE-43C1-9A3A-6BE26DA45BE7Q37107165-DB524A66-0220-426B-B70A-B47144C00272Q37365089-63B7C826-2112-4C2B-968A-C63843D759B6Q37384355-EB753DD9-91D7-4EB9-86F3-58C64E81ACC8Q38049624-8F8D07D5-7140-497D-ABCC-5CDB2EB4A2F4Q38083848-F0659A62-A501-4385-A193-425A8DF9C3D6Q38146845-AF1496DF-0156-45C0-826B-4A5FBE45AE66Q38698641-8D07454D-A887-4CE1-BD33-D5853E2C9B09Q38812933-58129089-5472-4826-83E6-DCAD6937E26DQ38921991-5487143E-A2FA-4ADC-9B9A-C68DD0B090EEQ40302404-4236E92E-5A4C-4AA1-BE8C-C656FD37B771Q40436165-D57A4D15-C46C-40C8-BFD1-D23BE12AC46BQ41332646-230E9F1C-6F8B-48F7-B42A-8AAA4390AADCQ41374598-630F2CB6-A585-4345-B6A6-61FAE1655328Q42789516-D6F503FC-4E34-424D-B9DB-B9DD6DB6A02CQ42973704-49450672-7DBB-4071-BDBE-D722BF93F5A8Q43931045-6DF63E1F-10A5-4F27-AD9E-829744FC6942Q43987083-94CB8CD4-C997-4ED3-B118-3EBD5C792F6EQ44056508-5C9699D7-7D48-47C6-9EB7-9DDE737AA971Q44205715-8E1FD3E3-9021-42F7-8A75-0BAB64704EB5Q44273588-AFA5147A-819F-4E5A-8120-4926CA2AE4F4Q44399669-17CFB004-F531-4370-89B4-53B57AA5ED2FQ44635214-31C40218-F6D0-4020-9A6A-6AD4B2B2496EQ44955638-116EE8E8-6C59-437F-B45C-274CF6BBD423Q45007356-B0CB2D8A-572F-48F1-898F-080BF533CE29
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Stefan M. Gold
@ast
Stefan M. Gold
@en
Stefan M. Gold
@es
Stefan M. Gold
@sl
type
label
Stefan M. Gold
@ast
Stefan M. Gold
@en
Stefan M. Gold
@es
Stefan M. Gold
@sl
prefLabel
Stefan M. Gold
@ast
Stefan M. Gold
@en
Stefan M. Gold
@es
Stefan M. Gold
@sl
P108
P214
P106
P108
P1153
16230351000
P21
P214
P31
P496
0000-0001-5188-4799
P734
P735
P7859
lccn-n2011185981